z-logo
open-access-imgOpen Access
Metanolic extract of Malpighia emarginata bagasse: phenolic compounds and inhibitory potential on digestive enzymes
Author(s) -
Tamara Rezende Marques,
Aline Aparecida Caetano,
Anderson Assaid Simão,
Flavia Cintia de Oliveira Castro,
Vinicius de Oliveira Ramos,
Angelita Duarte Corrêa
Publication year - 2016
Publication title -
revista brasileira de farmacognosia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.432
H-Index - 46
eISSN - 1981-528X
pISSN - 0102-695X
DOI - 10.1016/j.bjp.2015.08.015
Subject(s) - chemistry , gallic acid , lipase , food science , catechin , syringic acid , enzyme , bagasse , quercetin , chromatography , biochemistry , antioxidant , polyphenol , biology , microbiology and biotechnology
Adding value to fruit residues is of great interest, since they can be presented as a viable solution in search of new drugs for the treatment of obesity and related diseases, due to bioactive substances, especially phenolic compounds. Thus, the objective of this study was to prepare the methanol extract of acerola bagasse flour, in order to evaluate its potential as a source of inhibitors of the enzymes α-amylase, α-glucosidase, lipase and trypsin, and determine the content of phenolic compounds by high performance liquid chromatography. Enzymatic inhibition assays were conducted in the presence or absence of simulated gastric fluid. In the methanol extract of acerola bagasse flour, the following phenolic compounds were identified: gallic acid, syringic and p-coumaric acid, catechin, epigallocatechin gallate, epicatechin and quercetin; epicatechin was the major compound. In the absence of gastric fluid, simulated enzymes had a variable inhibition of the acerola bagasse flour extract, except for lipase, which was not inhibited. In the presence of simulated gastric fluid, there was an inhibition of 170.08IEU (Inhibited Enzyme Unit in μmolmin−1g−1) for α-amylase and 69.29IEU for α-glucosidase, indicating that this extract shows potential as an adjuvant in the treatment of obesity and other dyslipidemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here